FDA grants Novocure approval for electric field device targeting lung cancer
The FDA recently approved a revolutionary device by Novocure, named Optune Lua, designed to treat non-small cell lung cancer through the creation of electric fields. These fields, according to the manufacturer, interfere with the division of malignant cells, offering a new avenue of treatment when combined with standard therapies such as immunotherapy or chemotherapy. This […]